By

Steve Holtzman & Jeremy Levin

27
Nov
2017

Female Contraception, Health and Liberty

[Note: This article was first published on the Leadership and Biotechnology Blog.] Against the backdrop of tax reform, ongoing dialogue around sexual harassment, deepening investigations into the role of Russia in our elections, the crisis in Korea, attempts to dismantle the Affordable Care Act, and continued attempts to restrict immigration and remove Dreamers from the USA, President Trump’s assault on...
Read More
16
Aug
2017

At What Price a Seat at the Table?

[Editor’s Note: This editorial was co-authored by Steve Holtzman, CEO of Decibel Therapeutics, and Jeremy Levin, CEO of Ovid Therapeutics in the aftermath of violent clashes between white supremacists and counter-protesters in Charlottesville, Virginia.] FACT 1: The overwhelming majority of the men and women in the biopharmaceutical industry, scientists and non-scientists alike, have been drawn to their profession by the noble...
Read More